Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 4
1991 2
1992 1
1993 5
1994 2
1995 5
1996 3
1997 3
1998 3
1999 3
2000 2
2001 6
2002 7
2003 10
2004 5
2005 7
2006 11
2007 11
2008 5
2009 6
2010 7
2011 10
2012 12
2013 4
2014 5
2015 11
2016 13
2017 21
2018 17
2019 16
2020 22
2021 19
2022 18
2023 19
2024 19

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

273 results

Results by year

Filters applied: . Clear all
Page 1
Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL).
McInnes IB, Asahina A, Coates LC, Landewé R, Merola JF, Ritchlin CT, Tanaka Y, Gossec L, Gottlieb AB, Warren RB, Ink B, Assudani D, Bajracharya R, Shende V, Coarse J, Mease PJ. McInnes IB, et al. Among authors: asahina a. Lancet. 2023 Jan 7;401(10370):25-37. doi: 10.1016/S0140-6736(22)02302-9. Epub 2022 Dec 6. Lancet. 2023. PMID: 36493791 Free article. Clinical Trial.
Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE).
Merola JF, Landewé R, McInnes IB, Mease PJ, Ritchlin CT, Tanaka Y, Asahina A, Behrens F, Gladman DD, Gossec L, Gottlieb AB, Thaçi D, Warren RB, Ink B, Assudani D, Bajracharya R, Shende V, Coarse J, Coates LC. Merola JF, et al. Among authors: asahina a. Lancet. 2023 Jan 7;401(10370):38-48. doi: 10.1016/S0140-6736(22)02303-0. Epub 2022 Dec 6. Lancet. 2023. PMID: 36495881 Free article. Clinical Trial.
Bimekizumab treatment in biologic DMARD-naïve patients with active psoriatic arthritis: 52-week efficacy and safety results from the phase III, randomised, placebo-controlled, active reference BE OPTIMAL study.
Ritchlin CT, Coates LC, McInnes IB, Mease PJ, Merola JF, Tanaka Y, Asahina A, Gossec L, Gottlieb AB, Warren RB, Ink B, Bajracharya R, Shende V, Coarse J, Landewé RB. Ritchlin CT, et al. Among authors: asahina a. Ann Rheum Dis. 2023 Nov;82(11):1404-1414. doi: 10.1136/ard-2023-224431. Epub 2023 Sep 11. Ann Rheum Dis. 2023. PMID: 37696588 Free PMC article. Clinical Trial.
Bimekizumab treatment in patients with active psoriatic arthritis and prior inadequate response to tumour necrosis factor inhibitors: 52-week safety and efficacy from the phase III BE COMPLETE study and its open-label extension BE VITAL.
Coates LC, Landewé R, McInnes IB, Mease PJ, Ritchlin CT, Tanaka Y, Asahina A, Behrens F, Gladman DD, Gossec L, Orbai AM, Gottlieb AB, Warren RB, Ink B, Bajracharya R, Shende V, Coarse J, Merola JF. Coates LC, et al. Among authors: asahina a. RMD Open. 2024 Feb 22;10(1):e003855. doi: 10.1136/rmdopen-2023-003855. RMD Open. 2024. PMID: 38388171 Free PMC article. Clinical Trial.
Interstitial Pneumonia in Psoriasis.
Kawamoto H, Hara H, Minagawa S, Numata T, Araya J, Kaneko Y, Umezawa Y, Asahina A, Nakagawa H, Kuwano K. Kawamoto H, et al. Among authors: asahina a. Mayo Clin Proc Innov Qual Outcomes. 2018 Sep 20;2(4):370-377. doi: 10.1016/j.mayocpiqo.2018.07.006. eCollection 2018 Dec. Mayo Clin Proc Innov Qual Outcomes. 2018. PMID: 30560239 Free PMC article.
Safety and efficacy of mirikizumab versus secukinumab and placebo in the treatment of moderate-to-severe plaque psoriasis (OASIS-2): a phase 3, multicentre, randomised, double-blind study.
Papp K, Warren RB, Green L, Reich K, Langley RG, Paul C, Asahina A, Johnson L, Arora V, Osuntokun O, Lebwohl M. Papp K, et al. Among authors: asahina a. Lancet Rheumatol. 2023 Sep;5(9):e542-e552. doi: 10.1016/S2665-9913(23)00120-0. Epub 2023 Aug 21. Lancet Rheumatol. 2023. PMID: 38251498 Clinical Trial.
Bilateral segmental neurofibromatosis.
Nagaoka Y, Asahina A, Yano S, Tamaki K. Nagaoka Y, et al. Among authors: asahina a. Acta Derm Venereol. 2002;82(3):219-20. doi: 10.1080/00015550260132596. Acta Derm Venereol. 2002. PMID: 12353721 Free article. No abstract available.
Modulation of Langerhans cell function by epidermal nerves.
Asahina A, Hosoi J, Grabbe S, Granstein RD. Asahina A, et al. J Allergy Clin Immunol. 1995 Dec;96(6 Pt 2):1178-82. doi: 10.1016/s0091-6749(95)70203-2. J Allergy Clin Immunol. 1995. PMID: 8543775 Review.
Adult-onset generalized morphea associated with osteomyelitis.
Chihara M, Asahina A, Yanaba K. Chihara M, et al. Among authors: asahina a. J Dermatol. 2020 Dec;47(12):e446-e447. doi: 10.1111/1346-8138.15568. Epub 2020 Sep 3. J Dermatol. 2020. PMID: 32881032 No abstract available.
273 results